For example, in NSCLC circFGFR1 induces resistance to PD-1 antibodies by interacting with miR-381-3p and upregulating its target CXCR4, responsible for NSCLC progression and resistance [203]. Here, CXCR4 is linked to non-small cell lung carcinoma.